Search Research Articles
Browse Research Categories

ARA-290 Peptide Research

ARA-290 is a synthetic 11-amino-acid peptide derived from the helix B surface of erythropoietin (EPO), engineered to activate the innate repair receptor (IRR) without stimulating red blood cell production or carrying the thrombotic risks of full EPO. Research has explored its applications in neuropathic pain, particularly in small fiber neuropathy, as well as systemic inflammation, metabolic syndrome, tissue repair, and sarcoidosis. ARA-290 represents a novel approach to separating EPO’s tissue-protective properties from its hematopoietic activity. This section covers current scientific studies on ARA-290 and its neuroprotective, anti-inflammatory, and regenerative research applications.

Other Popular Research Categories

Newest ARA-290 Research

ARA-290 Peptide Research – Complete Guide

ARA-290 (cibinetide) is a synthetic 11-amino acid peptide derived from the helix B surface domain of erythropoietin, engineered to capture EPO's tissue-protective effects without triggering red blood cell production. This ARA-290 peptide research guide covers its primary mechanism through the Innate Repair Receptor, key findings from Phase 2 human trials in neuropathy and diabetes, preclinical evidence across neurological and cardiovascular...

About The Cenexa Labs Research Library

This section of the research library focuses on scientific studies involving and related research. The Cenexa Research Library compiles publicly available scientific literature and research summaries related to peptides, bioregulators, and signaling molecules. Our goal is to make complex scientific research easier to understand without requiring a technical background.
Scroll to Top
0